Key Points
Business NewsMarketsStocksNewsBusiness and valuation tailwinds to help in outperformance? 5 Indian pharma stocks with upside potential of up to 32%..
Just before the whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance was the Indian pharma companies, yes they are very different in every sense from MNC pharma..
During the PSU rally, these pharma stocks have been consolidating, however, in the last few days, some of them have once again started reacting to positive developments in the individual company indicating that there is money on the sideline that is ready to come into these stocks..
Sectors like pharma which have seen a very long phase of business remodelling and valuation readjustment need to be brought back on the watch list..
Second, which is more important and sustainable is that some sectors have gone through a phase, business remodelling and valuation readjustment has taken place and now the probability of..
You might be interested in
Getting ready for another round of re-rating ? 6 defence stocks with “buy” recos with upside potential of
25, Feb, 24As other sectors dominated by PSU companies come into limelight, defence stocks which ignited the re-rating of PSU stocks have moved into consolidation mode for some time. The question is whether the business is in consolidation mode or not, the answer is tilting toward no. It appears the underlying developments in the sector continue to be going at the same pace or rather even more. Allowing 100 % FDI in space related industries, is probably an indication that focus on defence and related sectors continues. As things are shaping up, it appears the exports would also become a focus area.
Ready for another round of re-rating even in a volatile market? 5 Indian pharma stocks with upside potenti
08, Mar, 24In the last two years, every sector has come into focus at one point of time or the other. Some came into limelight due to the fact of real positive changes in the fundamental operating matrix of that sector. While others came into focus just because of too much liquidity chasing Indian paper. In the case of the pharma sector, after years of consolidation, valuation readjustment and regulatory learning which altogether led to positive change in the fundamentals, the stocks made a comeback. It is almost a period of six to eight years that the industry is back on the list where there are more positive developments than negative. These changes have come after the management of a large number of pharma companies learnt the lesson hard way. The lessons that expansion based on PPT presentations on market growth are probably not the best way to run business, rather ensuring compliance to regulatory requirements is more important. So sectors like pharma which have seen a very long phase of business remodelling and valuation readjustment need to be brought back on the watch list.
Medicine for bearish markets: 5 Indian pharma stocks with upside potential of up to 32%
24, Oct, 23There are some sectors which are able to face bears in a better way. The reason, the operating matrix of those sectors is such that rising interest rates and other economic headwinds have little impact on their working because they are taking care of a need which is very basic in nature and if spending has to be done on that, it cannot be postponed. Pharmaceutical companies come into that category. This is not to say that there was a phase of almost 7 years that pharma stocks became under-performers. That was a very different reason, most of which have been taken care of. So there is a good chance that this time pharma stock will be able to tackle bears in a much better way.